![HFS HFS](https://data.pdbj.org/pdbjplus/data/cc/svg/HFS.svg) | HFS | 表記: | 1-(1-HYDROXY-5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE | 組成式: | C14 H17 N3 O3 S | SMILES: | O=S(=O)(c2c1ccnc(O)c1ccc2)N3CCCNCC3 | InChi: | InChI=1S/C14H17N3O3S/c18-14-12-3-1-4-13(11(12)5-7-16-14)21(19,20)17-9-2-6-15-8-10-17/h1,3-5,7,15H,2,6,8-10H2,(H,16,18) | 別名: | HYDROXYFASUDIL | 定義日: | 2005-10-26 | 最終更新日: | 2020-06-17 | 識別子(ID): | 5-(1,4-diazepan-1-ylsulfonyl)isoquinolin-1-ol |
|
![HFT HFT](https://data.pdbj.org/pdbjplus/data/cc/svg/HFT.svg) | HFT | 表記: | HYDROXYFLUTAMIDE | 組成式: | C11 H11 F3 N2 O4 | SMILES: | FC(F)(F)c1cc(ccc1[N+]([O-])=O)NC(=O)C(O)(C)C | InChi: | InChI=1S/C11H11F3N2O4/c1-10(2,18)9(17)15-6-3-4-8(16(19)20)7(5-6)11(12,13)14/h3-5,18H,1-2H3,(H,15,17) | 別名: | 2-HYDROXY-2-METHYL-N-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)PROPANAMIDE | 定義日: | 2005-09-06 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide |
|
![C1Q C1Q](https://data.pdbj.org/pdbjplus/data/cc/svg/C1Q.svg) | C1Q | 表記: | N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}-10-phenyldecanamide | 組成式: | C40 H71 N O9 | SMILES: | O=C(NC(COC1OC(C(O)C(O)C1O)CO)C(O)C(O)CCCCCCCCCCCCCC)CCCCCCCCCc2ccccc2 | InChi: | InChI=1S/C40H71NO9/c1-2-3-4-5-6-7-8-9-10-13-16-22-27-33(43)36(45)32(30-49-40-39(48)38(47)37(46)34(29-42)50-40)41-35(44)28-23-17-14-11-12-15-19-24-31-25-20-18-21-26-31/h18,20-21,25-26,32-34,36-40,42-43,45-48H,2-17,19,22-24,27-30H2,1H3,(H,41,44)/t32-,33+,34+,36-,37-,38-,39+,40-/m0/s1 | 別名: | (2S,3S,4R)-N-PHENYLDECANOYL-1-[(ALPHA-D-GALACTOPYRANOSYL)OXY]-2-AMINO-OCTADECANE-3,4-DIOL | 定義日: | 2009-04-07 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}-10-phenyldecanamide |
|
![HG1 HG1](https://data.pdbj.org/pdbjplus/data/cc/svg/HG1.svg) | HG1 | 表記: | 1-[(4-cyclohexylbutanoyl)(2-hydroxyethyl)amino]-1-deoxy-D-glucitol | 組成式: | C18 H35 N O7 | SMILES: | O=C(N(CC(O)C(O)C(O)C(O)CO)CCO)CCCC1CCCCC1 | InChi: | InChI=1S/C18H35NO7/c20-10-9-19(11-14(22)17(25)18(26)15(23)12-21)16(24)8-4-7-13-5-2-1-3-6-13/h13-15,17-18,20-23,25-26H,1-12H2/t14-,15+,17+,18+/m0/s1 | 別名: | C-HEGA-10 | 定義日: | 2013-10-16 | 最終更新日: | 2020-06-17 | 公開日: | 2013-12-11 | 識別子(ID): | 1-[(4-cyclohexylbutanoyl)(2-hydroxyethyl)amino]-1-deoxy-D-glucitol |
|
![HGD HGD](https://data.pdbj.org/pdbjplus/data/cc/svg/HGD.svg) | HGD | 表記: | mercury bis(L-gamma-glutamyl-3-sulfido-L-alanylglycine) | 組成式: | C20 H32 Hg N6 O12 S2 | SMILES: | O=C(NC(C(=O)NCC(=O)O)CS[Hg]SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)CCC(C(=O)O)N | InChi: | InChI=1S/2C10H17N3O6S.Hg/c2*11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16 | 別名: | S-Mercury glutathione | 定義日: | 2013-10-31 | 最終更新日: | 2020-06-17 | 公開日: | 2014-03-19 | 識別子(ID): | mercury bis(L-gamma-glutamyl-3-sulfido-L-alanylglycine) |
|
![C2A C2A](https://data.pdbj.org/pdbjplus/data/cc/svg/C2A.svg) | C2A | 表記: | 1-(3-CHLOROPHENYL)METHANAMINE | 組成式: | C7 H8 Cl N | SMILES: | Clc1cc(ccc1)CN | InChi: | InChI=1S/C7H8ClN/c8-7-3-1-2-6(4-7)5-9/h1-4H,5,9H2 | 別名: | INHIBITOR OF THROMBIN | 定義日: | 2005-12-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | 1-(3-chlorophenyl)methanamine |
|
![C2H C2H](https://data.pdbj.org/pdbjplus/data/cc/svg/C2H.svg) | C2H | 表記: | acetylene | 組成式: | C2 H2 | SMILES: | C#C | InChi: | InChI=1S/C2H2/c1-2/h1-2H | 別名: | ethyne | 定義日: | 2017-10-19 | 最終更新日: | 2020-06-17 | 公開日: | 2018-01-10 | 識別子(ID): | ethyne |
|
![HH3 HH3](https://data.pdbj.org/pdbjplus/data/cc/svg/HH3.svg) | HH3 | 表記: | (2S)-hydroxy[(phenylcarbonyl)amino]ethanoic acid | 組成式: | C9 H9 N O4 | SMILES: | O=C(NC(O)C(=O)O)c1ccccc1 | InChi: | InChI=1S/C9H9NO4/c11-7(10-8(12)9(13)14)6-4-2-1-3-5-6/h1-5,8,12H,(H,10,11)(H,13,14)/t8-/m0/s1 | 別名: | alpha-hydroxyhippuric acid | 定義日: | 2009-01-26 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2S)-hydroxy[(phenylcarbonyl)amino]ethanoic acid |
|
![HHG HHG](https://data.pdbj.org/pdbjplus/data/cc/svg/HHG.svg) | HHG | 表記: | (2R)-2-HYDROXY-3-(PHOSPHONOOXY)PROPYL HEXANOATE | 組成式: | C9 H19 O7 P | SMILES: | O=P(O)(O)OCC(O)COC(=O)CCCCC | InChi: | InChI=1S/C9H19O7P/c1-2-3-4-5-9(11)15-6-8(10)7-16-17(12,13)14/h8,10H,2-7H2,1H3,(H2,12,13,14)/t8-/m0/s1 | 別名: | 1-MONOHEXANOYL-2-HYDROXY-SN-GLYCERO-3-PHOSPHATE | 定義日: | 2005-01-05 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2S)-2-hydroxy-3-(phosphonooxy)propyl hexanoate |
|
![C3D C3D](https://data.pdbj.org/pdbjplus/data/cc/svg/C3D.svg) | C3D | 表記: | (5R,6S)-6-PHENYL-5-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]-5,6,7,8-TETRAHYDRONAPHTHALEN-2-OL | 組成式: | C28 H31 N O2 | SMILES: | O(c1ccc(cc1)C4c2ccc(O)cc2CCC4c3ccccc3)CCN5CCCC5 | InChi: | InChI=1S/C28H31NO2/c30-24-11-15-27-23(20-24)10-14-26(21-6-2-1-3-7-21)28(27)22-8-12-25(13-9-22)31-19-18-29-16-4-5-17-29/h1-3,6-9,11-13,15,20,26,28,30H,4-5,10,14,16-19H2/t26-,28+/m1/s1 | 別名: | Lasofoxifene | 定義日: | 2007-02-21 | 最終更新日: | 2020-06-17 | 識別子(ID): | (5R,6S)-6-phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol |
|
![HI6 HI6](https://data.pdbj.org/pdbjplus/data/cc/svg/HI6.svg) | HI6 | 表記: | 4-(AMINOCARBONYL)-1-[({2-[(E)-(HYDROXYIMINO)METHYL]PYRIDINIUM-1-YL}METHOXY)METHYL]PYRIDINIUM | 組成式: | C14 H16 N4 O3 | SMILES: | O=C(N)c1cc[n+](cc1)COC[n+]2ccccc2C=NO | InChi: | InChI=1S/C14H14N4O3/c15-14(19)12-4-7-17(8-5-12)10-21-11-18-6-2-1-3-13(18)9-16-20/h1-9H,10-11H2,(H-,15,19)/p+2 | 別名: | 1-(2-HYDROXY-IMINOMETHYLPYRIDINIUM)-1-(4-CARBOXYAMINO)-PYRIDINIUM DIMETHYLETHER | 定義日: | 2006-05-15 | 最終更新日: | 2020-06-17 | 識別子(ID): | 4-carbamoyl-1-[({2-[(E)-(hydroxyimino)methyl]pyridinium-1-yl}methoxy)methyl]pyridinium |
|
![HIA HIA](https://data.pdbj.org/pdbjplus/data/cc/svg/HIA.svg) | HIA | 表記: | L-HISTIDINE AMIDE | 組成式: | C6 H10 N4 O | SMILES: | O=C(N)C(N)Cc1cncn1 | InChi: | InChI=1S/C6H10N4O/c7-5(6(8)11)1-4-2-9-3-10-4/h2-3,5H,1,7H2,(H2,8,11)(H,9,10)/t5-/m0/s1 | 別名: | L-HISTIDINAMIDE | 定義日: | 2003-10-31 | 最終更新日: | 2020-06-17 | 識別子(ID): | L-histidinamide |
|
![HIU HIU](https://data.pdbj.org/pdbjplus/data/cc/svg/HIU.svg) | HIU | 表記: | (2R)-3-HYDROXY-2-METHYLPROPANOIC ACID | 組成式: | C4 H8 O3 | SMILES: | O=C(O)C(C)CO | InChi: | InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1 | 別名: | 3-HYDROXYISOBUTYRATE | 定義日: | 2005-03-29 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2R)-3-hydroxy-2-methylpropanoic acid |
|
![HIW HIW](https://data.pdbj.org/pdbjplus/data/cc/svg/HIW.svg) | HIW | 表記: | (2R,4S)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-[(2-{[(Z)-iminomethyl]amino}ethyl)sulfanyl]-3,4-dihydro-2H-pyrrole-5-ca
rboxylic acid | 組成式: | C12 H19 N3 O5 S | SMILES: | O=C(O)C1=NC(CC1SCCN[C@H]=N)C(C(O)=O)C(O)C | InChi: | InChI=1S/C12H19N3O5S/c1-6(16)9(11(17)18)7-4-8(10(15-7)12(19)20)21-3-2-14-5-13/h5-9,16H,2-4H2,1H3,(H2,13,14)(H,17,18)(H,19,20)/t6-,7-,8+,9-/m1/s1 | 別名: | Hydrolyzed Imipenem | 定義日: | 2015-12-24 | 最終更新日: | 2020-06-17 | 公開日: | 2016-05-11 | 識別子(ID): | (2R,4S)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-[(2-{[(Z)-iminomethyl]amino}ethyl)sulfanyl]-3,4-dihydro-2H-pyrrole-5-carboxylic acid |
|
![C4P C4P](https://data.pdbj.org/pdbjplus/data/cc/svg/C4P.svg) | C4P | 表記: | N-[(1R)-2-(BENZYLSULFANYL)-1-FORMYLETHYL]-N-(MORPHOLIN-4-YLCARBONYL)-L-PHENYLALANINAMIDE | 組成式: | C24 H29 N3 O4 S | SMILES: | O=C(NC(C(=O)NC(C=O)CSCc1ccccc1)Cc2ccccc2)N3CCOCC3 | InChi: | InChI=1S/C24H29N3O4S/c28-16-21(18-32-17-20-9-5-2-6-10-20)25-23(29)22(15-19-7-3-1-4-8-19)26-24(30)27-11-13-31-14-12-27/h1-10,16,21-22H,11-15,17-18H2,(H,25,29)(H,26,30)/t21-,22+/m1/s1 | 別名: | MORPHOLINE-4-CARBOXYLIC ACID [1-(2-BENZYLSULFANYL-1-FORMYL-ETHYLCARBAMOYL)-2-PHENYL-ETHYL]-AMIDE | 定義日: | 2003-02-11 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-[(1R)-2-(benzylsulfanyl)-1-formylethyl]-Nalpha-(morpholin-4-ylcarbonyl)-L-phenylalaninamide |
|
![HJ7 HJ7](https://data.pdbj.org/pdbjplus/data/cc/svg/HJ7.svg) | HJ7 | 表記: | (2Z)-4-oxobut-2-ene-1,2,4-tricarboxylic acid | 組成式: | C7 H6 O7 | SMILES: | C(C=C(CC(O)=O)C(O)=O)(=O)C(O)=O | InChi: | InChI=1S/C7H6O7/c8-4(7(13)14)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,9,10)(H,11,12)(H,13,14)/b3-1- | 別名: | (3Z)-2-keto-4-carboxy-3-hexenedioate | 定義日: | 2018-07-03 | 最終更新日: | 2020-06-17 | 公開日: | 2018-09-26 | 識別子(ID): | (2Z)-4-oxobut-2-ene-1,2,4-tricarboxylic acid |
|
![C5E C5E](https://data.pdbj.org/pdbjplus/data/cc/svg/C5E.svg) | C5E | 表記: | (1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE | 組成式: | C11 H14 N2 O | SMILES: | O=C1C=CC=C2N1CC3CNCC2C3 | InChi: | InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2/t8-,9+/m0/s1 | 別名: | CYTISINE | 定義日: | 2012-01-23 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1R,5S)-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one |
|
![HJX HJX](https://data.pdbj.org/pdbjplus/data/cc/svg/HJX.svg) | HJX | 表記: | 2-hydroxy-6-(tetradecyloxy)benzoic acid | 組成式: | C21 H34 O4 | SMILES: | O=C(O)c1c(O)cccc1OCCCCCCCCCCCCCC | InChi: | InChI=1S/C21H34O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-25-19-16-14-15-18(22)20(19)21(23)24/h14-16,22H,2-13,17H2,1H3,(H,23,24) | 別名: | BPH-981 | 定義日: | 2011-06-17 | 最終更新日: | 2020-06-17 | 公開日: | 2019-02-27 | 識別子(ID): | 2-hydroxy-6-(tetradecyloxy)benzoic acid |
|
![HKG HKG](https://data.pdbj.org/pdbjplus/data/cc/svg/HKG.svg) | HKG | 表記: | 1-{4-[5-({3-[(2-methylpyridin-3-yl)oxy]-5-[(pyridin-2-yl)sulfanyl]pyridin-2-yl}amino)-1,2,4-thiadiazol-3-yl]piperidin-1
-yl}ethan-1-one | 組成式: | C25 H25 N7 O2 S2 | SMILES: | c4(nc(Nc1ncc(cc1Oc2c(nccc2)C)Sc3ccccn3)sn4)C5CCN(CC5)C(C)=O | InChi: | InChI=1S/C25H25N7O2S2/c1-16-20(6-5-11-26-16)34-21-14-19(35-22-7-3-4-10-27-22)15-28-24(21)30-25-29-23(31-36-25)18-8-12-32(13-9-18)17(2)33/h3-7,10-11,14-15,18H,8-9,12-13H2,1-2H3,(H,28,29,30,31) | 別名: | AR453588 | 定義日: | 2018-07-09 | 最終更新日: | 2020-06-17 | 公開日: | 2019-07-10 | 識別子(ID): | 1-{4-[5-({3-[(2-methylpyridin-3-yl)oxy]-5-[(pyridin-2-yl)sulfanyl]pyridin-2-yl}amino)-1,2,4-thiadiazol-3-yl]piperidin-1-yl}ethan-1-one |
|
![HKT HKT](https://data.pdbj.org/pdbjplus/data/cc/svg/HKT.svg) | HKT | 表記: | 1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonyl-pyrrol-3-yl]-~{N}-methyl-methanamine | 組成式: | C17 H16 F N3 O2 S | SMILES: | CNCc1cn(c(c1)c2ccccc2F)[S](=O)(=O)c3cccnc3 | InChi: | InChI=1S/C17H16FN3O2S/c1-19-10-13-9-17(15-6-2-3-7-16(15)18)21(12-13)24(22,23)14-5-4-8-20-11-14/h2-9,11-12,19H,10H2,1H3 | 別名: | Vonoprazan | 定義日: | 2017-10-20 | 最終更新日: | 2020-06-17 | 公開日: | 2018-04-11 | 識別子(ID): | 1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonyl-pyrrol-3-yl]-~{N}-methyl-methanamine |
|
![C6H C6H](https://data.pdbj.org/pdbjplus/data/cc/svg/C6H.svg) | C6H | 表記: | 1-(7-chloranyl-4-methoxy-1~{H}-indol-5-yl)-3-[1-(cyclohexylmethyl)piperidin-4-yl]propan-1-one | 組成式: | C24 H33 Cl N2 O2 | SMILES: | COc1c(cc(Cl)c2[nH]ccc12)C(=O)CCC3CCN(CC3)CC4CCCCC4 | InChi: | InChI=1S/C24H33ClN2O2/c1-29-24-19-9-12-26-23(19)21(25)15-20(24)22(28)8-7-17-10-13-27(14-11-17)16-18-5-3-2-4-6-18/h9,12,15,17-18,26H,2-8,10-11,13-14,16H2,1H3 | 別名: | MR28926 | 定義日: | 2017-11-15 | 最終更新日: | 2020-06-17 | 公開日: | 2018-11-21 | 識別子(ID): | 1-(7-chloranyl-4-methoxy-1~{H}-indol-5-yl)-3-[1-(cyclohexylmethyl)piperidin-4-yl]propan-1-one |
|
![HL4 HL4](https://data.pdbj.org/pdbjplus/data/cc/svg/HL4.svg) | HL4 | 表記: | N-[(3S)-2-oxotetrahydrofuran-3-yl]butanamide | 組成式: | C8 H13 N O3 | SMILES: | O=C1OCCC1NC(=O)CCC | InChi: | InChI=1S/C8H13NO3/c1-2-3-7(10)9-6-4-5-12-8(6)11/h6H,2-5H2,1H3,(H,9,10)/t6-/m0/s1 | 別名: | N-butyryl-L-homoserine lactone | 定義日: | 2010-09-06 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-[(3S)-2-oxotetrahydrofuran-3-yl]butanamide |
|
![HL6 HL6](https://data.pdbj.org/pdbjplus/data/cc/svg/HL6.svg) | HL6 | 表記: | N-[(3S)-2-oxotetrahydrofuran-3-yl]hexanamide | 組成式: | C10 H17 N O3 | SMILES: | O=C1OCCC1NC(=O)CCCCC | InChi: | InChI=1S/C10H17NO3/c1-2-3-4-5-9(12)11-8-6-7-14-10(8)13/h8H,2-7H2,1H3,(H,11,12)/t8-/m0/s1 | 別名: | N-hexanoyl-L-homoserine lactone | 定義日: | 2011-02-15 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-[(3S)-2-oxotetrahydrofuran-3-yl]hexanamide |
|
![C6Q C6Q](https://data.pdbj.org/pdbjplus/data/cc/svg/C6Q.svg) | C6Q | 表記: | N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}-6-phenylhexanamide | 組成式: | C36 H63 N O9 | SMILES: | O=C(NC(COC1OC(C(O)C(O)C1O)CO)C(O)C(O)CCCCCCCCCCCCCC)CCCCCc2ccccc2 | InChi: | InChI=1S/C36H63NO9/c1-2-3-4-5-6-7-8-9-10-11-12-18-23-29(39)32(41)28(26-45-36-35(44)34(43)33(42)30(25-38)46-36)37-31(40)24-19-14-17-22-27-20-15-13-16-21-27/h13,15-16,20-21,28-30,32-36,38-39,41-44H,2-12,14,17-19,22-26H2,1H3,(H,37,40)/t28-,29+,30+,32-,33-,34-,35+,36-/m0/s1 | 別名: | (2S,3S,4R)-N-PHENYLHEXANOYL-1-[(ALPHA-D-GALACTOPYRANOSYL)OXY]-2-AMINO-OCTADECANE-3,4-DIOL | 定義日: | 2009-04-06 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}-6-phenylhexanamide |
|
![C76 C76](https://data.pdbj.org/pdbjplus/data/cc/svg/C76.svg) | C76 | 表記: | 2,2,2-tris(fluoranyl)-N-[(2R,3R,4R,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]ethanamide | 組成式: | C8 H12 F3 N O6 | SMILES: | OC[CH]1O[CH](O)[CH](NC(=O)C(F)(F)F)[CH](O)[CH]1O | InChi: | InChI=1S/C8H12F3NO6/c9-8(10,11)7(17)12-3-5(15)4(14)2(1-13)18-6(3)16/h2-6,13-16H,1H2,(H,12,17)/t2-,3-,4-,5-,6-/m1/s1 | 別名: | N-trifluoroacetyl-D-glucosamine | 定義日: | 2019-04-12 | 最終更新日: | 2020-06-17 | 公開日: | 2020-05-13 | 識別子(ID): | 2,2,2-tris(fluoranyl)-~{N}-[(2~{R},3~{R},4~{R},5~{S},6~{R})-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]ethanamide |
|